As ADN 423 moves into Phase III pivotal trials, the pharmaceutical community is watching closely. If the drug continues to demonstrate efficacy in protecting the liver and stabilizing blood glucose without the burden of weight gain or cardiovascular risk, it could displace current frontline therapies.
Select your preferred wellness centre from the list above
Click on “View Details” to explore centre-specific information
Follow the step-by-step instructions provided under “Online Booking” on the centre page
As ADN 423 moves into Phase III pivotal trials, the pharmaceutical community is watching closely. If the drug continues to demonstrate efficacy in protecting the liver and stabilizing blood glucose without the burden of weight gain or cardiovascular risk, it could displace current frontline therapies.
Copyright © 2026 Patanjali Wellness.
